Skip to main content
. 2011 Sep 21;20(2):176–179. doi: 10.1038/ejhg.2011.171

Table 2. Clinical features of patients with deletion of 1q43–q44.

Patient 1 2 3 4 5 6
Age (years) 2 7 6 11 3.5 17
Sex M F F M F F
Age at evaluation 6 months 2 years 3 years 9 years 11 months 7.5 years
Reason for aCGH Right sex cord stromal tumor, GDD GDD, microcephaly, CCA Microcephaly Microcephaly, GDD, seizures, TOF Microcephaly, genito-urinary abnormalities, VSD Mild DD
FOC (centile) <3 <5 <5 <3 <3 50
Wt (centile) 40 <5 <5 30 25 57
HT (centile) 90 50 <5 NA 50 75
             
Cranio-facial dysmorphism
 Head Microcephaly, flat occiput Microcephaly Microcephaly with brachycephaly Microcephaly Microcephaly Normal
 Facial dysmorphic features Hypertelorism Depressed nasal bridge +
             
Nervous system
 Developmental delay GDD GDD GDD GDD GDD Mild DD
 Seizures + +
 Hypotonia +
 Behavioral issues Aggressive Anxiety
 Structural brain abnormalities ACC, temporal pachygyria, occipital polymicrogyria Thinning of corpus callosum and hypoplasia of splenium, prominent cisterns with cerebral volume loss ACC, mild simplification of cerebral gyri Severe thinning of corpus callosum, small cerebral hemispheres, dilated subarchnoid space, cerebellar atrophy None None
Heart None None ASD TOF VSD None
Other organ system involvement Sex cord stromal tumor None Polysyndactyly of toes Hirschsprung disease Renal hypoplasia and ureteral duplication None

Abbreviations: ACC, agenesis of corpus callosum; CCA, corpus callosum abnormalities; DD, developmental delay; GDD, global developmental delay; NA, data not available, TOF, Tetralogy of Fallot; VSD, ventricular septal defect.